{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:41:28Z","timestamp":1756464088303},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.cyto.2013.07.018","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T00:16:05Z","timestamp":1376352965000},"page":"97-102","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Assessment of serum IGF-1 and adipokines related to metabolic dysfunction in HIV-infected adults"],"prefix":"10.1016","volume":"64","author":[{"given":"Anna","family":"Parfieniuk-Kowerda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u0142awomir Lech","family":"Czaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Grzeszczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Jaroszewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Flisiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2013.07.018_b0005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0140-6736(00)02504-6","article-title":"AIDS across Europe, 1994\u201398: the EuroSIDA study","volume":"356","author":"Mocroft","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2013.07.018_b0010","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/135965350601100502","article-title":"Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration","volume":"11","author":"Jaroszewicz","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cyto.2013.07.018_b0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jinf.2010.06.002","article-title":"The HIV-1\/HAART associated metabolic syndrome \u2013 novel adipokines, molecular associations and therapeutic implications","volume":"61","author":"Tsiodras","year":"2010","journal-title":"J Infect"},{"issue":"1046","key":"10.1016\/j.cyto.2013.07.018_b0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/QAD.0b013e32834e8776","article-title":"Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment","volume":"26","author":"Capeau","year":"2012","journal-title":"Aids"},{"key":"10.1016\/j.cyto.2013.07.018_b0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2337\/diab.45.1.91","article-title":"Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes","volume":"45","author":"Moses","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.cyto.2013.07.018_b0030","first-page":"205","article-title":"Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance","volume":"79","author":"Morrow","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cyto.2013.07.018_b0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1530\/EJE-10-0963","article-title":"Prediction of incident diabetes mellitus by baseline IGF1 levels","volume":"164","author":"Schneider","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cyto.2013.07.018_b0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/01.ATV.18.2.277","article-title":"Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease","volume":"18","author":"Janssen","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cyto.2013.07.018_b0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11154-013-9245-9","article-title":"Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV\/AIDS","volume":"14","author":"Jain","year":"2013","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.cyto.2013.07.018_b0050","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s10620-008-0585-3","article-title":"Adipose tissue: the new endocrine organ? A review article","volume":"54","author":"Wozniak","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cyto.2013.07.018_b0055","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2362.2006.01699.x","article-title":"Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects","volume":"36","author":"Schindler","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cyto.2013.07.018_b0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cyto.2012.01.013","article-title":"Leptin and adiponectin, but not IL18, are related with insulin resistance in treated HIV-1-infected patients with lipodystrophy","volume":"58","author":"Veloso","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2013.07.018_b0065","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2013.07.018_b0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cmet.2007.06.002","article-title":"Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass","volume":"6","author":"Kloting","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.cyto.2013.07.018_b0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/eje.0.1480293","article-title":"The role of the novel adipocyte-derived hormone adiponectin in human disease","volume":"148","author":"Diez","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cyto.2013.07.018_b0080","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.febslet.2008.01.023","article-title":"Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes","volume":"582","author":"Takahashi","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cyto.2013.07.018_b0085","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.cyto.2013.07.018_b0090","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","article-title":"Visfatin, an adipocytokine with proinflammatory and immunomodulating properties","volume":"178","author":"Moschen","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2013.07.018_b0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/jc.2005-1475","article-title":"Elevated plasma level of visfatin\/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus","volume":"91","author":"Chen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cyto.2013.07.018_b0100","unstructured":"The Oxford Centre for Diabetes, Endocrinology and Metabolism. Diabetes Trial Unit. HOMA Calculator., January 2012. <www.dtu.ox.ac.uk>"},{"key":"10.1016\/j.cyto.2013.07.018_b0105","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.cyto.2013.07.018_b0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3851\/IMP1916","article-title":"Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort","volume":"17","author":"Boufassa","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cyto.2013.07.018_b0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11154-013-9247-7","article-title":"Insulin resistance, lipodystrophy and cardiometabolic syndrome in HIV\/AIDS","volume":"14","author":"Galescu","year":"2013","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.cyto.2013.07.018_b0120","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/meta.2002.29999","article-title":"Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution","volume":"51","author":"Meininger","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.cyto.2013.07.018_b0125","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1080\/08035250510028362","article-title":"Abnormalities in plasma fatty acid composition in human immunodeficiency virus-infected children treated with protease inhibitors","volume":"94","author":"Aldamiz-Echevarria","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.cyto.2013.07.018_b0130","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4158\/EP10098.RA","article-title":"The pathway from diabetes and obesity to cancer, on the route to targeted therapy","volume":"16","author":"Gallagher","year":"2010","journal-title":"Endocr Pract"},{"key":"10.1016\/j.cyto.2013.07.018_b0135","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1210\/en.2007-0175","article-title":"Chemerin is a novel adipokine associated with obesity and metabolic syndrome","volume":"148","author":"Bozaoglu","year":"2007","journal-title":"Endocrinology"},{"issue":"Suppl 1","key":"10.1016\/j.cyto.2013.07.018_b0140","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S1665-2681(19)31829-0","article-title":"Insulin resistance and steatosis in chronic hepatitis C","volume":"8","author":"Machado","year":"2009","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cyto.2013.07.018_b0145","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1478-3231.2009.02095.x","article-title":"Immunogenetic susceptibility to diabetes mellitus in patients with liver disease","volume":"29","author":"Montano-Loza","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.cyto.2013.07.018_b0150","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1445-5994.2009.02042.x","article-title":"Change of insulin sensitivity in hepatitis C patients with normal insulin sensitivity: a 5-year prospective follow-up study variation of insulin sensitivity in HCV patients","volume":"40","author":"Park","year":"2010","journal-title":"Intern Med J"},{"issue":"Suppl 2","key":"10.1016\/j.cyto.2013.07.018_b0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1478-3231.2008.01952.x","article-title":"Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data","volume":"29","author":"Serfaty","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.cyto.2013.07.018_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabet.2008.08.003","article-title":"Metabolic disorders and chronic viral disease: the case of HIV and HCV","volume":"35","author":"Slama","year":"2009","journal-title":"Diabetes Metab"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466613006339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466613006339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T20:47:37Z","timestamp":1688417257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466613006339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1043466613006339"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2013.07.018","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of serum IGF-1 and adipokines related to metabolic dysfunction in HIV-infected adults","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2013.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2013 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}